Neumarker Enters Collaboration on Precision Medicine for Depression
Neumarker announced a collaboration focused on advancing precision medicine in depression.
Related stories
Broadstone Net Lease Q3 2026 Earnings Call Begins
Broadstone Net Lease's quarterly earnings call has begun.
M impact | EQUITY | Oct 29, 2026, 02:57 PM UTC
Forestar Group’s Q4 2026 Earnings Call Begins
Forestar Group’s quarterly earnings call has begun.
M impact | EQUITY | Oct 29, 2026, 02:57 PM UTC
Wacker Chemie Q3 2026 Earnings Call Begins
Wacker Chemie's Q3 2026 earnings call has begun.
M impact | EQUITY | Oct 29, 2026, 02:57 PM UTC
Teck Resources Q3 2026 Earnings Call Begins
Teck Resources' Q3 2026 earnings call has begun.
M impact | EQUITY | Oct 29, 2026, 02:57 PM UTC
Ibn Al Haytham Hospital Reports Q3 Loss of 327,659 Dinars
M impact | EQUITY | Oct 29, 2026, 02:57 PM UTC
Farmland Partners’ Q3 2026 Earnings Call Begins
Farmland Partners’ quarterly earnings call has begun.
M impact | EQUITY | Oct 29, 2026, 02:57 PM UTC